Shareholders in regenerative medicine company Mesobast have voted almost unanimously in favour of the company acquiring its US subsidiary Angioblast Systems, increasing its 32.6 percent stake to full ownership.
Researchers from the University of Wollongong’s (UOW) Schools of Chemistry and Health Sciences have been awarded a US patent for their novel method of characterising lipid molecules.
The Australian Stock Market just managed to stayed ahead for the week this week, as weakness from major sectors pushed down on the market.
Research Australia today announced the appointment of Dr Christine Bennett as its new chair.
Australia’s biggest healthcare provider Ramsay Healthcare this week reported a 21.9 percent jump in full-year net profit to $178.5 million.
Troubled HIV drug developer Avexa may be poised for yet another coup after major shareholder Caldaza this week called for an extraordinary general meeting to discuss the future of the company
Regenerative medicine specialists Mesoblast today reported a net loss of $14.8 million for the full year ended 30 June 2010, an increase on the previous year’s loss of $12.3 million.
Regenerative medicine specialists Mesoblast today reported a net loss of $14.8 million for the full year ended 30 June 2010. The company, noted, however that it had finished the year with cash reserves of $32.5 million, up from $16.5 million for the previous corresponding period.
Regenerative medicine specialists Mesoblast announced this week that it has convened an extraordinary general meeting with shareholders to vote on the proposed acquisition of the company’s US partner Angioblast Systems.
In an exclusive interview with Australian Life Scientist federal minister for Innovation, Industry, Science and Research Senator Kim Carr has launched a scathing attack on the federal opposition’s lack of vision on science and innovation warning that a victory for Tony Abbott tomorrow would represent a huge backward step for the nation.
Professor Philip Hogg, Director of the new Lowy Cancer Research Centre at the University of NSW, has received the prestigious 2010 Industry & Investment NSW Eureka Prize for Medical Research Translation.
This year’s prestigious GlaxoSmithKline Australia Award for Research has gone to Monash University’s Professor Charles Mackay for his work on immunology and inflammation, particularly the discovery of GPR43 as a major regulator of innate and inflammatory response.
Monash University has announced the appointment of esteemed Australian scientist and medical researcher Professor Scott O’Neill as the University’s new Dean of Science.
The federal Labor party reached out for the science vote today with the announcement of its Science for Australia’s Future policy, although there’s little there explicitly for life sciences or the biotechnology industry.
The staggering amounts of data being generated in genomics, epigenomics, proteomics and other ‘omics studies - not to mention systems biology, which attempts to knit the various ‘omics together - is presenting a titanic challenge for life science researchers.